We have been following the discussions and news reports about reducing the number of doses, extending the length of time between doses, changing the dose (half-dose), or mixing and matching vaccines in order to immunize more people against COVID-19. As the first round of vaccine recipients become eligible to receive their second dose, we want to remind the public about the importance of receiving COVID-19 vaccines according to how they’ve been authorized by the FDA in order to safely receive the level of protection observed in the large randomized trials supporting their effectiveness. Two different mRNA vaccines have now shown remarkable effectiveness of about 95% in preventing COVID-19 disease in adults.
Director - Center for Biologics Evaluation and Research (CBER) Commissioner of Food and Drugs - Food and Drug Administration For Immediate Release: JanuStatement From:
